Malaysia
Posted on
Minister Claims Imported Sofosbuvir Supply Enough For Malaysian Hepatitis C Patients
MOH said last November that 4,500 Malaysians were treated with generics of sofosbuvir.
Tag: Gilead Sciences
Compulsory licencing may not necessarily guarantee widespread access of remdesivir to Covid-19 patients in Malaysia.
Wall Street analysts suggest remdesivir could be priced between US5,000-US10,000 for a 10-day course of treatment.
Gilead Sciences has excluded Malaysia from receiving generic versions of remdesivir.
Three Opposition MPs say Malaysia can’t afford to spend as much on health care as Singapore or other Asian...
The only three Asean countries excluded by Gilead Sciences for generic versions of remdesivir in its new licencing agreements...
Letter
Posted on
Include Malaysia And Other Middle-Income Countries in All Licensing Agreements For Covid-19 Diagnostics, Treatments, And Vaccines — MHC & DNDi
Gilead excluded Malaysia, among other middle-income countries, from distribution of Remdesivir to 127 nations under voluntary licensing.
Unwarranted high prices for medications could lead to preventable deaths, said a study.
The trial saw most patients with severe Covid-19 discharged within six days.